Advanced Search
CHEN Xi, XIAO Yan-yu, CHEN Yi-nan, PING Qi-neng, ZHANG Can. Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 412-417.
Citation: CHEN Xi, XIAO Yan-yu, CHEN Yi-nan, PING Qi-neng, ZHANG Can. Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 412-417.

Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

More Information
  • Curcumin (Cur) loaded nanostructured lipid carriers(Cur-NLC) was prepared by melt-emulsification method.The physicochemical properties such as morphology,particles size,Zeta potential,entrapment efficiency and drug-loading capability were evaluated.Dialysis method was employed to investigate the release of Cur-NLC in vitro.In addition,the pharmacokinetics in rats receiving oral dosing of Cur-NLC and Cur-dispersion was investigated by HPLC method and analyzed by DAS2.0 pharmacokinetic software.The result showed that Cur-NLC was quasi-spherical shapes observed by TEM and the mean particle size,Zeta potential,entrapment efficiency drug-loading capability and were (187.5±4.67)nm,(-23.65±2.86)mV,(98.33±0.40)% and (4.59±0.19)%,respectively.The cumulative release of Cur-NLC in 36 h was lower than that of Cur-dispersion in HCl (pH 1) and PBS (pH 6.8) (19.2% vs 84.2% and 24.3% vs 90.2%) and the release characteristic of Cur-NLC and Cur-dispersion displayed a first-order process and Peppas process,respectively.After oral administration the AUC and cmax of Cur-NLC were 19.12-fold and 17.22-fold higher than those of Cur-dispersion (621.14±179.92)ng·h/mL vs (32.49±3.55)ng·h/mL and (92.81±38.52)ng/mL vs (5.39±0.13) ng/mL.In conclusion,Cur-NLC exhibited high encapsulation efficiency and drug loading capability,possessed sustained release in vitro and improved the oral absorption and bioavailability of Cur when compared with Cur-dispersion.
  • Related Articles

    [1]Studies on Pharmacokinetics and Relative Bioavailability of Aceclofenac Controlled-Release Tablets in Dogs[J]. Journal of China Pharmaceutical University, 2004, (5): 57-59.
    [2]Relative Bioavailability and Pharmacokinetics of Roxithromycin Dispersive Tablets in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2004, (4): 41-43.
    [3]Pharmacokinetics and Bioavailability of Cinnamic Acid in Mice[J]. Journal of China Pharmaceutical University, 2004, (4): 38-40.
    [4]Study on the Relative Bioavailability and Pharmacokinetics of Metformin Controlled-release Tablets in Human Volunteers[J]. Journal of China Pharmaceutical University, 2003, (5): 52-55.
    [5]Pharmacokinetics of 0325k1-1 in Dogs[J]. Journal of China Pharmaceutical University, 2003, (4): 79-81.
    [6]Pharmacokinetic and Relative Bioavailability of Gliclazide Tablets After a Single Oral Administration in Healthy Subjects[J]. Journal of China Pharmaceutical University, 1998, (3): 67-70.
    [7]Pharmacokinetics and Relative Bioavailability of Cyclosporin Pearls in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1996, (6): 20-22.
    [8]Pharmacokinetics and Relative Bioavailability of Tamoxifen in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1995, (2): 84-86.
    [9]Pharmacokinetics and Pharmacodynamics of Sophocarpine and Oxysophocarpine[J]. Journal of China Pharmaceutical University, 1992, (3): 161-164.
    [10]PHARMACOKINETICS OF MATRINR IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (4): 309-311.

Catalog

    Article views (2321) PDF downloads (2899) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return